Y-Biologics, Inc. (KOSDAQ:338840)
South Korea flag South Korea · Delayed Price · Currency is KRW
23,550
-850 (-3.48%)
At close: Dec 29, 2025

Y-Biologics Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
342,336113,678230,299---
Upgrade
Market Cap Growth
205.52%-50.64%----
Upgrade
Enterprise Value
319,211102,035230,749---
Upgrade
Last Close Price
22900.007690.0015600.00---
Upgrade
PS Ratio
94.7819.7366.19---
Upgrade
PB Ratio
24.865.798.86---
Upgrade
P/TBV Ratio
25.536.279.94---
Upgrade
EV/Sales Ratio
88.3817.7166.33---
Upgrade
Debt / Equity Ratio
1.390.040.110.250.210.16
Upgrade
Asset Turnover
0.100.220.120.120.110.16
Upgrade
Quick Ratio
1.1510.587.391.602.913.35
Upgrade
Current Ratio
1.1610.737.481.703.203.78
Upgrade
Return on Equity (ROE)
-49.24%-28.23%-90.84%-77.73%-54.50%-40.90%
Upgrade
Return on Assets (ROA)
-14.21%-20.30%-21.27%-34.84%-24.67%-11.53%
Upgrade
Return on Capital (ROIC)
-19.51%-21.41%-23.57%-39.71%-29.35%-16.78%
Upgrade
Return on Capital Employed (ROCE)
-59.20%-41.10%-37.00%-90.60%-54.20%-20.30%
Upgrade
Earnings Yield
-2.55%-5.67%-9.06%---
Upgrade
FCF Yield
-1.67%-6.16%-3.39%---
Upgrade
Buyback Yield / Dilution
-3.46%-19.30%-1.87%-1.01%-21.93%-5.25%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.